Dr. O'Connor is a leader in the field of oncology drug discovery and development. His contributions include over 100 publications and patents, and over 20 compounds brought into development (e.g., Axitinib (VEGF, PII/PIII), AG14699/PF-01367338 (PARP, PII/III), Crizotinib (C-Met/ALK, PII/III)), RDEA119/BAY869766 (MEK, Phase I/II).
The event includes buffet dinner, desert and soft drinks/wine. Because there are a limited number of spaces available, it is advisable to register soon.
Contact the organizer for latest event info. Kodoom.com is not responsible for any changes made in the above information. Report or Flag this event
